1. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – an update;Jermain;Int. J. Pharm. (Amst.),2018
2. C. Leuner, J. Dressman, Improving drug solubility for oral delivery using solid dispersions, n.d. www.elsevier.com/locate/ejphabio.
3. A. Therapeutics Good Association, AusPAR Attachment 1: Product Information for Neratinib (as maleate), n.d. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.tga.gov.au/sites/default/files/auspar-neratinib-as-maleate-020512-pi.pdf (accessed June 12, 2024).
4. USFDA, Product information label for NERLYNX, (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208051s009lbl.pdf (accessed December 26, 2023).
5. Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs;Maleki;J. Contr. Release,2017